The athlete biological passport: An integral element of innovative strategies in antidoping

British Journal of Sports Medicine

Volumn 48, Issue 10, 2014, Pages 817-819

  Vernec, Alan R ^a  

^a World Anti Doping Agency (WADA)   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORMANCE ENHANCING SUBSTANCE;

ATHLETE; DOPING; ETHICS; HUMAN; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PROCEDURES; SPORT; STANDARDS; SUBSTANCE ABUSE;

ATHLETES; DOPING IN SPORTS; GUIDELINES AS TOPIC; HUMANS; INTERNATIONAL AGENCIES; PERFORMANCE-ENHANCING SUBSTANCES; SPORTS; SUBSTANCE ABUSE DETECTION;

EID: 84899911433     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2014-093560     Document Type: Article

References (12)

1. International Amateur Athletic Federation. 'Section 13: Doping' Handbook of the International Amateur Athlete Federation 1927-1928. 1928. Web. 16 December2013. http://www.iaaf.org/news/news/a-piece-of-anti-doping-history-iaaf- handbook
2. Sawka MN, Convertino VA, Eichner ER, et al. Blood volume: Importance and adaptations to exercise training, environmental stresses, and trauma/sickness. Med Sci Sports Exerc 2000;32:332-48. (Pubitemid 30108111)
3. Schumacher YO, Wenning M, Robinson N, et al. Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes. Int J Sports Med 2010;31:225-30.
4. World Anti-Doping Agency. 'Athlete biological passport operating guidelines & compilation of required elements, version 4.0. November 2013'. World Anti-Doping Agency, 2013. Web. 16 December 2013. http://www.wada-ama.org/ Documents/ Science-Medicine/Athlete-Biological-Passport/WADA-ABP-Operating- Guidelines-v4.0-EN.pdf
5. Zorzoli M, Rossi F. Case studies on ESA-doping as revealed by the Biological Passport. Drug Test Anal 2012;4:854-8.
6. World Anti-Doping Agency. 'Testing Figures'. World Anti-Doping Agency. Web. 16 December 2013. http://www.wada-ama.org/en/Resources/Testing-Figures/
7. Zorzoli M, Rossi F. Implementation of the biological passport: The experience of theInternational Cycling Union. Drug Test Anal 2010;2:542-7.
8. Schumacher YO, Pottgiesser T. Performance profiling: A role for sport science in the fight against doping? Int J Sports Physiol Peform 2009;4:129-33.
9. Sottas PE, Robinson N, Fischetto G, et al. Prevalence of blood doping in samplescollected from elite track and field athletes. Clin Chem 2011;57:762-9.
10. Sottas PE, Saugy M, Saudan C. Endogenous steroid profiling in the athletebiological passport. Endocrinol Metab Clin North Am 2010;39:59-73,viii- ix.
11. Schulze JJ, Lundmark J, Garle MJ, et al. Doping test results dependent on genotypeof uridinediphospho-glucuronosyltransferase 2B17, the major enzyme for testosterone glucuronidation. Clin Endocrinol Metab 2008;93:2500-6. (Pubitemid 352008513)
12. World Anti-Doping Agency. 'International Standard for the Protection of Privacy andPersonal Information'. World Anti-Doping Agency. Web. 16 December 2013. http://www. wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti- Doping-Organizations/ The-Code/Code-Review/International-Standards-1st- Consultation-Phase1/ISPPPI-Protection-of-Privacy-and-Personal-Information/